France · Investor

Innoven Partners

No cheque observed since Jul 2011, after 11 earlier cheques, and the website is dead.

DormantInvestment firm

Series ASeries BVentureBiotechnologySoftware

Cheques on record
0%of best year0cheques in 12 months, 11 on record
Since the last cheque5591days00hrs00min00sec
Median round$9.1MRounds led0 of 11Sole investor1 roundsExits2 from the portfolioMostly inUnited States, 40%
Pitch Innoven Partners

Innoven Partners highlights

  1. 01

    11 rounds on record

  2. 02

    Mostly Series A and Series B: 50% of its rounds

  3. 03

    Sole investor in 1 rounds, median $4.0M

  4. 04

    2 exits from the portfolio

What they do

Type
Investment firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologySoftware
Based in
France
Cold pitches
Not stated

The record

Every round we can evidence, newest first11 appearances

  1. 2011

    1 round

  2. Jul
    SpineVisionVenture · FR · finsmes.com$5.0MWith 3 others
  3. 2010

    2 rounds

  4. Oct
    Club CooeeSeries B · DE · en.blog.clubcooee.comUndisclosedWith 3 others
  5. Jan
    EyeGate PharmaceuticalsSeries D · US · finsmes.com$23MWith 3 others
  6. 2009

    2 rounds

  7. Sept
    SpineGuardSeries A · US · onbiovc.com$4.0MWith 4 others
  8. Mar
    BioVexSeries F · GB · fiercebiotech.com$40MWith 7 others
  9. 2008

    2 rounds

  10. Jul
    Monte CristoVenture · thealarmclock.com$7.0MWith 2 others
  11. Mar
    EyeGate PharmaceuticalsSeries C · US · eyegatepharma.com$15MWith 3 others
  12. 2007

    1 round

  13. Nov
    BioVexSeries E · GB$35MWith 10 others
  14. 2006

    2 rounds

  15. Dec
    NAVXSeries A · FR · gpsbusinessnews.com$4.0MSole investor
  16. Nov
    EyeGate PharmaceuticalsSeries B · US · eyegatepharma.com$10MWith 1 other
  17. 2004

    1 round

  18. Mar
    gate5Series A · DE · ieg-banking.com$8.1MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

BioVexBought by Amgen$1.0BJan 2011
gate5Bought by HERE, a Nokia companyUndisclosedAug 2006

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Innoven Partners. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Innoven Partners

What does Innoven Partners invest in?

Innoven Partners invests most often at Series A and Series B (50% of the rounds on record), in sectors such as Biotechnology and Software.

How active is Innoven Partners?

11 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2011.

How big are Innoven Partners's cheques?

The median round it joins is $9.1M.

Does Innoven Partners lead rounds?

Rarely, if at all: none of its 11 investments on record names it as the lead.

Where does Innoven Partners invest?

Most of the companies it backs are in the United States (40%), France (20%) and Germany (20%).

Is Innoven Partners investing now?

It looks quiet: no investment on record since Jul 2011.

Who does Innoven Partners invest alongside?

Most often Ventech (3 rounds together), Crédit Agricole (2 rounds together) and Harris & Harris Group (2 rounds together).

What kind of investor is Innoven Partners?

Innoven Partners is an investment firm based in France.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it